https://www.pfizer.com/news/press-release/press-release-detail/talazoparib_significantly_extends_progression_free_survival_in_phase_3_embraca_trial_of_patients_with_metastatic_breast_cancer
Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients...
Pfizer Inc. (NYSE:PFE) today announced that the Phase 3 EMBRACA trial in patients with germline (inherited) BRCA1/2-positive (gBRCA+) locally advanced and/or...
progression free survival
https://www.mdanderson.org/newsroom/archived-news/therapeutic-melanoma-vaccine-improves-response-rate-progression-.h00-158672634.html
ARCHIVED: Therapeutic Melanoma Vaccine Improves Response Rate, Progression-Free Survival | UT MD...
progression free survivalmelanoma vaccineresponse rate
https://www.mdanderson.org/newsroom/archived-news/everolimus-improves-progression-free-survival-for-patients-with-.h00-158990601.html
ARCHIVED: Everolimus improves progression-free survival for patients with advanced, nonfunctional...
progression free survivalfor patientsarchivedeverolimusimproves
https://www.rti.org/publication/cost-median-month-progression-free-survival-daratumumab-plus-bortezomib-and-dexamethasone-compared
Cost per median month of progression-free survival for daratumumab plus bortezomib and...
Background: New treatments for relapsed/refractory multiple myeloma have recently been FDA approved in the United States (US). For FDA approval, these...
progression free survival
https://www.mdanderson.org/newsroom/archived-news/parp-inhibitor-improves-progression-free-survival-in-patients-with-advanced-breast-cancers-and-BRCA-mutations.h00-159226512.html
ARCHIVED: PARP inhibitor improves progression-free survival in patients with advanced breast...
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended...
progression free survivalparp inhibitor
https://www.healthday.com/healthpro-news/cancer/asco-osimertinib-improves-progression-free-survival-in-egfr-mutated-lung-cancer
Osimertinib Ups Progression-Free Survival in EGFR-Mutated Lung Cancer
For patients with unresectable stage III EGFR-mutated non-small cell lung cancer, treatment with osimertinib results in significantly longer progression-free...
progression free survivalosimertinibupsegfrmutated
https://www.businesswire.com/news/home/20231022739040/en/Datopotamab-Deruxtecan-Improved-Progression-Free-Survival-Versus-Chemotherapy-in-Patients-with-Previously-Treated-Non-Small-Cell-Lung-Cancer-in-TROPION-Lung01-Phase-3-Trial
Datopotamab Deruxtecan Improved Progression-Free Survival Versus Chemotherapy in Patients with...
Datopotamab Deruxtecan Improved Progression-Free Survival Vs. Chemo in Previously Treated Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
progression free survivaldatopotamab deruxtecanin patientsimproved
https://www.mdedge.com/b-cell-lymphoma-icymi/article/257549/lung-cancer/evaluating-progression-free-survival-among-veteran
Evaluating Progression Free Survival Among Veteran Population With Stage IV Non-Small Cell...
progression free survival
https://www.mdanderson.org/newsroom/archived-news/everolimus-improves-progression-free-survival-for-patients-with-.h00-158669478.html
ARCHIVED: Everolimus Improves Progression-Free Survival for Patients with Rare Pancreatic Cancer |...
progression free survival
https://www.mdanderson.org/newsroom/metastasis-directed-radiation-therapy-plus-hormone-therapy-improves-progression-free-survival-for-men-with-advanced-prostate-cancer.h00-159543690.html
radiation therapy plus hormone therapy improves progression-free survival for men with advanced...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone...
progression free survivalradiation therapy
https://www.rti.org/publication/radiographic-progression-free-survival-correlation-time-event-endpoints-post-hoc
Radiographic progression-free survival correlation with time-to-event endpoints | RTI
progression free survivaltime toradiographiccorrelation
https://www.mdanderson.org/newsroom/archived-news/everolimus-improves-progression-free-survival-for-patients-with-.h00-158596890.html
ARCHIVED: Everolimus Improves Progression-Free Survival for Patients with Rare Pancreatic Cancer |...
progression free survival
https://www.mdanderson.org/newsroom/archived-news/everolimus-prolongs-progression.h00-158676579.html
ARCHIVED: Everolimus Prolongs Progression-Free Survival for Patients with Neuroendocrine Tumors |...
progression free survivalfor patientsarchivedeverolimus
https://www.cancer.gov/news-events/press-releases/2018/sorafenib-desmoid-trial
Sorafenib improved progression-free survival in desmoid tumor study - NCI
In an NCI-funded trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF), rare sarcomas with limited treatment options, the drug sorafenib...
progression free survivaldesmoid tumorsorafenibimprovedstudy
https://www.preprints.org/manuscript/202406.1840
Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer With Long-Term...
The optimal timing for actively discontinuing immune checkpoint inhibitor therapy in long-term responders with recurrent/metastatic head and neck squamous cell...
progression free survival
https://www.mdanderson.org/newsroom/archived-news/progression-free-sur.h00-159067134.html
ARCHIVED: Progression-free survival triples in select metastatic lung cancer patients with surgery...
Lung cancer patients with oliogometastases, defined as three or fewer sites of metastasis, may benefit from aggressive local therapy, surgery or radiation,...
progression free survival
https://pmc.ncbi.nlm.nih.gov/articles/PMC2654812/
Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials:...
Progression-free survival is an important end point in advanced disease settings. Blinded independent central review (BICR) of progression in randomized...
progression free survival
https://www.mayo.edu/research/clinical-trials/cls-20590000?p=1
A Study To Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax...
progression free survival
https://www.mayo.edu/research/clinical-trials/cls-20590000
A Study To Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax...
Learn more about services at Mayo Clinic.
progression free survival
https://www.prnewswire.com/news-releases/lillys-jaypirca-pirtobrutinib-significantly-extended-progression-free-survival-when-added-to-a-venetoclax-time-limited-regimen-in-patients-with-previously-treated-cllsll-302739912.html
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca (pirtobrutinib),...
progression free survival
https://www.aacr.org/about-the-aacr/newsroom/news-releases/adding-capivasertib-to-fulvestrant-improves-progression-free-survival-in-patients-with-advanced-hormone-receptor-positive-breast-cancer/
Adding Capivasertib to Fulvestrant Improves Progression-free Survival in Patients With Advanced...
Adding Capivasertib to Fulvestrant Improves Progression-free Survival in Patients With Advanced Hormone Receptor-positive Breast Cancer
progression free survival
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-03665&r=1
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax...
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab...
progression free survival